Experimental osteonecrosis: development of a model in rodents administered alendronate

AUTOR(ES)

CONTE NETO, Nicolau, SPOLIDORIO, Luis Carlos, ANDRADE, Cleverton Roberto de, ESTEVES, Jônatas Caldeira, MARCANTONIO JR, Elcio

FONTE

Braz. oral res.

DATA DE PUBLICAÇÃO

22/08/2016

RESUMO

Abstract The main objective of this study was to cause bisphosphonate-related osteonecrosis of the jaws to develop in a rodent model. Adult male Holtzman rats were assigned to one of two experimental groups to receive alendronate (AL; 1 mg/kg/week; n = 6) or saline solution (CTL; n = 6). After 60 days of drug therapy, all animals were subjected to first lower molar extraction, and 28 days later, animals were euthanized. All rats treated with alendronate developed osteonecrosis, presenting as ulcers and necrotic bone, associated with a significant infection process, especially at the inter-alveolar septum area and crestal regions. The degree of vascularization, the levels of C-telopeptide cross-linked collagen type I and bone-specific alkaline phosphatase, as well as the bone volume were significantly reduced in these animals. Furthermore, on radiographic analysis, animals treated with alendronate presented evident sclerosis of the lamina dura of the lower first molar alveolar socket associated with decreased radiographic density in this area. These findings indicate that the protocol developed in the present study opens new perspectives and could be a good starting model for future property design.

Documentos Relacionados

• Different Differentiation of Stroma Cells from Patients with Osteonecrosis: A Pilot Study
• Human islet xenotransplantation in rodents: A literature review of experimental model trends
• Medication-related osteonecrosis of the jaw. Introduction of a new modified experimental model
• Development of experimental in vitro burn model
• Experimental Intra-Abdominal Abscesses in Rats: Development of an Experimental Model